
|Articles|March 4, 2009
GSK and UCL team up
GlaxoSmithKline (GSK) and University College London's Institute of Ophthalmology have agreed a deal in which the Institute will investigate the potential of compounds provided by GSK's ophthalmic unit, Ophthiris.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retinal imaging as a window into atrial fibrillation
2
The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD
3
OCT-980 receives FDA orphan drug designation for retinitis pigmentosa
4
First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP
5


















